These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21114826)

  • 1. Randomised controlled trial of the clinical and cost effectiveness of a specialist team for managing refractory unipolar depressive disorder.
    Morriss R; Marttunnen S; Garland A; Nixon N; McDonald R; Sweeney T; Flambert H; Fox R; Kaylor-Hughes C; James M; Yang M
    BMC Psychiatry; 2010 Nov; 10():100. PubMed ID: 21114826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial.
    Morriss R; Garland A; Nixon N; Guo B; James M; Kaylor-Hughes C; Moore R; Ramana R; Sampson C; Sweeney T; Dalgleish T;
    Lancet Psychiatry; 2016 Sep; 3(9):821-31. PubMed ID: 27498098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial.
    Goodyer IM; Tsancheva S; Byford S; Dubicka B; Hill J; Kelvin R; Reynolds S; Roberts C; Senior R; Suckling J; Wilkinson P; Target M; Fonagy P
    Trials; 2011 Jul; 12():175. PubMed ID: 21752257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial.
    Serfaty M; King M; Nazareth I; Tookman A; Wood J; Gola A; Aspden T; Mannix K; Davis S; Moorey S; Jones L
    Trials; 2016 Feb; 17(1):113. PubMed ID: 26926910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial.
    Overend K; Lewis H; Bailey D; Bosanquet K; Chew-Graham C; Ekers D; Gascoyne S; Hems D; Holmes J; Keding A; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Parrott S; Richards D; Traviss G; Trépel D; Woodhouse R; Gilbody S
    Trials; 2014 Nov; 15(1):451. PubMed ID: 25409776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial.
    Richards DA; Hill JJ; Gask L; Lovell K; Chew-Graham C; Bower P; Cape J; Pilling S; Araya R; Kessler D; Bland JM; Green C; Gilbody S; Lewis G; Manning C; Hughes-Morley A; Barkham M
    BMJ; 2013 Aug; 347():f4913. PubMed ID: 23959152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients.
    Walker J; Cassidy J; Sharpe M;
    Trials; 2009 Mar; 10():18. PubMed ID: 19331675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial.
    de Graaf LE; Gerhards SA; Evers SM; Arntz A; Riper H; Severens JL; Widdershoven G; Metsemakers JF; Huibers MJ
    BMC Public Health; 2008 Jun; 8():224. PubMed ID: 18590518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial.
    Richards D; Duffy D; Blackburn B; Earley C; Enrique A; Palacios J; Franklin M; Clarke G; Sollesse S; Connell S; Timulak L
    BMC Psychiatry; 2018 Mar; 18(1):59. PubMed ID: 29499675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.
    Karyotaki E; Tordrup D; Buntrock C; Bertollini R; Cuijpers P
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):501-516. PubMed ID: 27328966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How is a specialist depression service effective for persistent moderate to severe depressive disorder?: a qualitative study of service user experience.
    Thomson L; Barker M; Kaylor-Hughes C; Garland A; Ramana R; Morriss R; Hammond E; Hopkins G; Simpson S
    BMC Psychiatry; 2018 Jun; 18(1):194. PubMed ID: 29902995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.